High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

L. Serfaty, S. Pianko, Z. Ben Ari, A. L. Laursen, Jesper Bach Hansen, E. J. Gane, H. C. Huang, Shidai Jin, J. Bourque, H. Liu, A. Grandhi, Mei Su, N. Gendrano, D. Fernsler, F. Dutko, B. Y. T. Nguyen, J. Wahl, E. Barr, W. Yeh, R. PlankJ. R. Butterton

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerTHU-264
TidsskriftJournal of Hepatology
Vol/bind66
Udgave nummer1
Sider (fra-til)S306-S307
ISSN0168-8278
DOI
StatusUdgivet - 2017
Begivenhed The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver - Amsterdam, Holland
Varighed: 19 apr. 201723 apr. 2017

Konference

Konference The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver
Land/OmrådeHolland
ByAmsterdam
Periode19/04/201723/04/2017

Citationsformater